Identification of mixed anaerobic infections after inguinal hernia repair based on metagenomic next-generation

Jun Zhang1, Yuming Zhou1, Zhenzhou Zhong1

  • 1Department of Emergency Medicine, Ganzhou People's Hospital, Ganzhou, 341000, China.

PubMed

Insights

Post-inguinal hernia repair infections are rare but challenging. Metagenomic next-generation sequencing (mNGS) accurately identified a mixed bacterial infection, improving patient outcomes.

Area of Science:

  • Infectious Diseases
  • Surgical Site Infections
  • Microbiology

Background:

  • Infections following inguinal hernia repair (IHR) are infrequent but can complicate patient recovery.
  • Accurate identification of causative pathogens is crucial for effective antibiotic therapy but often challenging.
  • Standard culture methods may not detect all microorganisms involved in complex infections.

Observation:

  • A patient presented with intermittent fever after open preperitoneal tension-free bilateral inguinal hernia repair.
  • Scrotal fluid culture identified *Enterococcus faecalis*.
  • Metagenomic next-generation sequencing (mNGS) detected *E. faecalis* and multiple anaerobic bacteria, including *Bacteroides thetaiotaomicron*, *Parabacteroides distasonis*, and *Levyella massiliensis*.

Findings:

  • mNGS revealed a mixed infection involving *E. faecalis* and several anaerobic species, a finding missed by culture alone.
  • The patient's condition improved significantly after antibiotic regimen adjustment based on comprehensive mNGS results.
  • mNGS proved valuable in confirming culture findings and aiding in the differential diagnosis of potential hematogenous spread infections.

Implications:

  • Metagenomic next-generation sequencing (mNGS) offers superior diagnostic accuracy for complex postoperative infections compared to traditional cultures.
  • This case highlights the potential for polymicrobial anaerobic infections after IHR.
  • mNGS can guide targeted antibiotic therapy, leading to better patient outcomes and potentially reducing the need for broad-spectrum antibiotics.